concerns about increased mortality with Maxipime (cefepime)
January 2008
Please see updated information from the FDA
The FDA is raising concerns about increased mortality with Maxipime (cefepime).
Maxipime is a broad-spectrum IV cephalosporin used for sicker patients with nosocomial pneumonia and other resistant infections.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote